DAVITA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137.5 USD | -0.30% |
|
+2.28% | +31.27% |
| May. 07 | TD Cowen Adjusts Price Target on DaVita to $139 From $136 | MT |
| May. 03 | UBS Adjusts Price Target on DaVita to $169 From $145, Maintains Buy Rating | MT |
Presenter SpeechAndrew Mok (Analysts)Good afternoon, and welcome back to the Barclays Global H...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows:
- supply of dialysis services (95.3%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2023, services are insured through 2,675 dialysis centers serving nearly 200,800 patients in the United States, and through 367 dialysis centers serving nearly 49,400 patients abroad;
- other (4.7%).
Calendar
2024-05-14
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
137.5
USD
Average target price
141.1
USD
Spread / Average Target
+2.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +31.27% | 12.06B | |
| +20.68% | 85.55B | |
| -29.31% | 70.07B | |
| +6.76% | 28.95B | |
| -8.63% | 17.51B | |
| +1.92% | 17.39B | |
| +0.39% | 15.38B | |
| +6.47% | 13.4B | |
| +68.09% | 12.93B | |
| +5.30% | 12.77B |
- Stock Market
- Equities
- DVA Stock
- News DaVita Inc.
- Transcript : DaVita Inc. Presents at Barclays Global Healthcare Conference 2021, Mar-10-2021 04